baber/WOPTO huggingface dataset:
Patent DE-69509173-T2 (DE)
Inventor: NESTOR JOHN J
IPC: A61K31/52
Filed: 1995-07-19
Granted: 1999-10-21
Abstract: The L-monovaline ester derived from 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol and its pharmaceutically acceptable salts are disclosed which are of value as antiviral agents with improved absorption.
Patent DE-69513436-T2 (DE)
Inventor: DEVONALD DAVID H III
IPC: H01H33/56
Filed: 1995-03-20
Granted: 2000-03-23
Abstract: A switchgear module (20) is provided that is assembled from one or more molded housing portions (50,60,70) to provide a gas-tight volume for the housing of electrical components (21,23). The switchgear modules (20) include provisions for assembly of various combinations of switchgear modules (25,26,27,28) into a variety of electrical circuit configurations while maintaining a gas seal of the switchgear modules (20). In a preferred arrangement, the switchgear module (20) includes bus conductors (22) that are integrally incorporated during the molding of the switchgear module housing and that are accessible from opposite sides of the module. Further, the switchgear module (20) includes integrally molded features (24) for providing access to make electrical interconnections between the bus conductors (22) of adjacently positioned switchgear modules (20). Thus, the finally assembled and tested switchgear modules (20) with pressurized internal volume may be configured to provide a variety of different electrical circuit combinations of the internal components and are also capable of being reconfigured as desired into different configurations or lineups without the loss of the seal of the interior volume of the switchgear modules. The switchgear module (20) includes a complete internal and integral system to satisfy desirable operating practices to deenergize, test and ground the circuit before working thereon. Specifically, the switchgear module (20) includes an integral indicator (228,216) with test feature, a visible open gap in the circuit which is readily observable externally to the module, and a ground position (33) for the internal switch to ground the circuit. In a preferred arrangement, an operating mechanism (40) is internal to the module (20) and controls the position of either a loadbreak switch (21) or a disconnect switch between three operable positions, close, open, and ground. The operating mechanism (40) is charged and operated by an operating train (44,49) that is connected to an operator control (48). <IMAGE>
Patent DE-69517769-T2 (DE)
Inventor: EUZEN PATRICK
IPC: B01J23/58
Filed: 1995-11-10
Granted: 2001-01-25
Abstract: Combustion catalyst comprises a monolithic support; 100-400 g/l porous refractory inorganic oxide support; 0.3-20 wt.% Ce; 0.01-3.5 wt.% Fe; and 3-20 g/l Pd and/or Pt.
Patent DE-69518729-T2 (DE)
Inventor: GORFINE STEPHEN R
IPC: A61K9/02
Filed: 1995-04-10
Granted: 2001-05-31
Abstract: A pharmaceutical composition contains a nitric oxide donor and advantageously an optional corticosteroid and/or topical anaesthetic. The composition is useful in a method for treating anal disorders such as anal fissure, anal ulcer, hemorrhoidal disease, levator spasm, and so forth, by topical application to or proximate the affected area.
Patent DE-69521813-T2 (DE)
Inventor: SORSA ARTO
IPC: G01N33/573
Filed: 1995-04-12
Granted: 2002-04-11
Abstract: PCT No. PCT/FI95/00213 Sec. 371 Date Dec. 11, 1996 Sec. 102(e) Date Dec. 11, 1996 PCT Filed Apr. 12, 1995 PCT Pub. No. WO96/32647 PCT Pub. Date Oct. 17, 1996The present invention is related to a rapid and reliable method for making chair-side diagnoses of periodontal diseases and especially for predicting the risk of progressing of the periodontal diseases. The diagnosis and prognosis are performed using an immunological test kit by which increased levels of neutrophil gelatinase-related lipocalin (NGAL) derived from polymorphonuclear neutrophilic leucocytes PMNs) is measured.
Patent DE-69523298-T2 (DE)
Inventor: HIDAKA HIROYOSHI
IPC: C07D213/42
Filed: 1995-04-05
Granted: 2002-06-27
Abstract: The invention relates to an aminostilbazole derivative of the following formula or a hydrate thereof, and a salt thereof. <CHEM> wherein R<1> and R<2> each represents hydrogen etc.; R<3>, R<4>, R<13>, and R<14> each represents hydrogen, C1-3 acyl, halogen, hydroxy etc.; R<5> represents hydrogen or hydroxy-substituted C1-3 alkyl etc.; R<6> represents benzenesulfonyl substituted by C1-3 alkoxy etc.; ring Y represents phenyl etc.; ring Z represents 4-pyridyl, its oxide etc. The compound is useful for the treatment of various malignant tumors.
Patent DE-69534310-T2 (DE)
Inventor: SCOTT P
IPC: C12N5/02
Filed: 1995-10-06
Granted: 2006-04-27
Abstract: Invertebrate and vertebrate  patched  genes are provided, including the mouse and human  patched  genes, as well as methods for isolation of related genes, where the genes may be of different species or in the same family. Having the ability to regulate the expression of the  patched  gene, allows for the elucidation of embryonic development, cellular regulation associated with signal transduction by the  patched  gene, the identification of agonist and antagonist to signal transduction, identification if ligands for binding to  patched,  isolation of the ligands, and assaying for levels of transcription and expression of the  patched  gene.
Patent DE-69600507-T2 (DE)
Inventor: ROSSINI FELICE
IPC: B41F27/10
Filed: 1996-03-01
Granted: 1999-04-15
Abstract: A printing cylinder mandrel (1) arranged to support a sleeve mounted on it and carrying the print characters, the mandrel (1) being surface-deformable and able to assume at least two configurations, in one of which the sleeve can be mounted on it and in the other of which the sleeve is torsionally locked to it, the mandrel (1) comprising a core (2) the surface of which is covered with a deformable element (8), between this latter and said core there being provided a plurality of intercommunicating perimetral chambers (10) containing an incompressible fluid; the mandrel (1) internally houses presser means (20) arranged to pressurize said fluid in order to achieve the surface deformation of the mandrel (1) and the torsional coupling and locking of the sleeve, said presser means (20) being guidedly movable within the mandrel (1) and being activated by feeding into this latter a pressurized fluid. <IMAGE>
Patent DE-69604328-T2 (DE)
Inventor: WENGER BENOIT
IPC: B65D1/36
Filed: 1996-05-03
Granted: 1999-12-30
Abstract: The package comprises a panel (1) with a series of individual recesses (11,12) for the articles. Detachable domes (2) are shaped to clip over the recesses, covering them. The inner surface of each dome also has a zone (28) to engage with the article inside it. Each dome also has a section or label which is at least partially transparent to give a view of the article inside it. The panel is made with lines (15) of reduced strength and with holes (16) at their intersections to allow individual sections to be separated. The panel and the domes are made from a synthetic, recyclable or biodegradable material, e.g. the panel can be of polystyrene and the domes of polypropylene.
Patent DE-69619311-T2 (DE)
Inventor: NYGREN MATS
IPC: C30B1/10
Filed: 1996-07-04
Granted: 2002-10-17
Abstract: The presently claimed invention relates to a method of producing, in large volumes and at low cost, titanium carbide, nitride and carbonitride whiskers, with preferably submicron diameters, to be used as reinforcing material. The whiskers are suitable for use as a reinforcement material in a wide range of materials, including metals, intermetallics, plastics, ceramics and metallic bonded hard material. Titanium oxide, hydroxide or alkali compounds thereof are mixed with the carbon powder. The basic idea of the invention is the use of a carbon source with a volatile part which volatiles at temperatures exceeding 500 DEG C and in an amount to satisfy the stoichiometric requirements of the carbide or nitride and use a halogenide salt as a volatilisation agent for titanium and a catalyst able to dissolve Ti plus C and/or N, such as Ni or Co. The reactant powders are blended in some typical manner e.g. by using a high speed blender so as to intimately mix them. Finally the mixed starting material is subjected to nitriding, carbonising or carbo-nitriding heat treatments in order to produce the desired whiskers. <IMAGE>
Patent DE-69619596-T2 (DE)
Inventor: MILIANI RACHID
IPC: F25C5/00
Filed: 1996-06-14
Granted: 2002-09-19
Abstract: The present invention relates to a device for dosing and dispensing solid substances such as ice (3), which device is provided with at least one storage chamber (1), at least one discharge opening (8), at least one movable feed element (5) which is arranged between the storage chamber and the discharge opening and has at least one receiving space (7), and means (9) for dosing the quantity of solid substance to be dispensed through the discharge opening. A solid substance such as ice can hereby be dosed and dispensed quickly and hygienically. A suitable choice of the volume of the storage chamber in relation to the adjusted quantity of solid substance for dispensing ensures an uninterrupted operation of the device. <IMAGE>
Patent DE-69626826-T2 (DE)
Inventor: KELLY DENISE
IPC: A23L1/30
Filed: 1996-07-15
Granted: 2004-01-29
Abstract: The present invention relates to a polypeptide growth factor derived from colostrum (CDGF) having defined chemical and biological characteristics. The factor may be prepared from porcine or bovine colostrum and pharmaceutical uses thereof may include combatting invasion of the body by pathogens, wound healing, promoting organ growth and development and promoting adaption of the gastrointestinal tract to diet change.
Patent DE-69632528-T2 (DE)
Inventor: OLSSON BERT-AKE
IPC: B65B55/04
Filed: 1996-09-06
Granted: 2005-05-12
Abstract: A transfer device for aseptic and automatic transfer of filled, unsealed pharmaceutical containers (2) which comprises a transport vehicle (11) with a vertically adjustable platform (12) supporting a transportable and sealable chamber (1). The chamber (1) comprises an upper part (8) provided with a protective-gas inlet (7), a lower part (9) provided with a frame (13) for supporting the containers (2), a closable opening (14), and an intermediate, substantially horizontal flow distributor (10).
Patent DE-69704882-T2 (DE)
Inventor: BEUKERS ADRIAAN
IPC: B62D29/04
Filed: 1997-01-15
Granted: 2001-12-20
Abstract: Self-supporting refrigerated truck comprising a floor, two side walls, a front bulkhead and a roof. The components are all constructed as sandwich panels. The connection between the rear axle construction of the refrigerated truck and the front is not provided with longitudinal beams. The function of the chassis is taken over by the side walls (9), which are capable of absorbing loads because the skin and sandwich panels of the side walls have appreciable strength and a fill of appreciable compressive strength is also fitted. In order to transmit forces into the side walls it is proposed to accommodate the vertically extending trusses in said side walls, which trusses are joined to cross-members of the rear axle construction which extend over the entire width. The fixing for the floor and side wall comprises a section (23) which has four flanges, which preferably extend perpendicularly, with a first flange close to the inner limit of the side wall, a second flange close to the top of the floor, a third flange as a continuation of the second flange and extending in the thickness of the side wall and a fourth flange comprising a continuation of the first flange in the floor or the boundary between floor and side wall. <IMAGE>
Patent DE-69709639-T2 (DE)
Inventor: ROSSEN KAI
IPC: C07C59/125
Filed: 1997-05-27
Granted: 2002-08-08
Abstract: The invention encompasses a process for making compounds of formula (I) or (Ia) useful in the treatment of cyclooxygenase-2 mediated diseases.
Patent DE-69711728-T2 (DE)
Inventor: WEISSER GERMAN LOUIS
IPC: F01D25/16
Filed: 1997-01-10
Granted: 2002-10-17
Abstract: A sealless turbine generator mounted on a single shaft comprising a radial turbine having a unique thrust equalizing mechanism mounted thereto and operative with a portion of the applied hydraulic fluid to the turbine radial runner and a thrust bearing for equalizing the generated thrust forces by providing a small axial, bidirectional movement of the thrust bearing and the elements mounted on the single shaft and an induction generator driven by the turbine. The shaft along with the induction generator and the turbine components except the turbine runner are isolated in a common housing and the entire assembly included in a submersible containment vessel having a fluid inlet and outlet for receiving the input hydraulic fluid flow at a preselected fluid pressure and velocity for controlling the speed of the turbine. The induction generator includes a variable frequency, exciting current source for the generator stator windings that permits changing the synchronous speed of the generator as required by the hydraulic fluid flow and hydraulic fluid head to permit the overall efficiency of the turbine generator to be optimized. The turbine generator is operative with liquified gases that may be utilized to lubricate and cool the thrust bearing and the induction generator by the small portion of the operative fluid utilized for operating the thrust equalizing mechanism. <IMAGE>
Patent DE-69721095-T2 (DE)
Inventor: WARNER DAVID B
IPC: A61F2/34
Filed: 1997-01-31
Granted: 2004-03-04
Abstract: A prosthetic hip cup comprises a porous hemispherical shell (10), a constraining ring (14) and a moulded polyethylene component (16). The hemispherical shell (10) is formed from fibre metal mesh, and the moulded component (16) is formed from ultra high molecular weight polyethylene (UHMWP) material.
Patent DE-69721499-T2 (DE)
Inventor: PAI M
IPC: A61L2/24
Filed: 1997-02-11
Granted: 2004-04-08
Abstract: The invention is a system and method for real-time monitoring and control of sterilization cycle parameters within a load-simulation device that simulates the same conditions as those within an acceptable standard challenge load to be sterilized. Integration of the device into the sterilizer control system allows critical sterilization parameter levels to be achieved and maintained within the simulated load throughout a sterilization cycle, thus resulting in a significant reduction in the number of unsuccessful cycles. A redundant parameter-monitoring system within the device is included. When acceptable sterilization parameter levels are shown to have been met, the sterile load is automatically released for use immediately upon completion of the cycle, thus eliminating the need for biological indicators and chemical integrators.
Patent DE-69722858-T2 (DE)
Inventor: SATO ATSUSHI
IPC: A61K31/407
Filed: 1997-01-16
Granted: 2004-05-13
Abstract: The present invention is directed to an intimal hypertrophy inhibitor containing as the active ingredient an oxyindole derivative represented by the following formula (I) or a salt thereof: <CHEM> (wherein R<1> represents a hydrogen atom; a phenyl group which may be substituted by a lower alkyl group, a lower alkoxy group, a lower alkylaminoalkoxy group, a hydroxy group, an amino group, a lower alkylamino group, or a halogen atom; or a pyridyl group which may be substituted by a lower alkyl group, a lower alkoxy group, a lower alkylaminoalkoxy group, a hydroxy group, an amino group, a lower alkylamino group, a halogen atom, a lower alkoxycarbonyl group, or a carboxyl group; R<2> represents a phenyl group which may be substituted; or a pyridyl group which may be substituted by a lower alkyl group, a lower alkoxy group, a lower alkylaminoalkoxy group, a hydroxy group, an amino group, a lower alkylamino group, a halogen atom, a lower alkoxycarbonyl group, or a carboxyl group; R<3> represents a hydrogen atom; a lower alkyl, benzyl, or a benzenesulfonyl group which may be substituted; or an acyl group; R<4> represents a hydrogen atom; a lower alkoxy group, a halogen atom, an amino group, a lower alkylamino group, a carboxyl group, a lower alkoxycarbonyl group; a phenylcarbomoyl group which may be substituted; or a trifluoromethyl group; X represents CH or N; n represents a number between 0 and 4 inclusive that indicates the number of substituents; and the broken/solid double line denotes a single bond or a double bond). The intimal hypertrophy inhibitor of the present invention exhibits excellent inhibitory action against intimal hypertrophy, and thus is useful as a preventive/therapeutic/ameliorating agent for proliferative vascular diseases such as restenosis after PTCA, arteriosclerosis, peripheral embolism, and angiitis.
Patent DE-69723198-T2 (DE)
Inventor: SUDO MORIHIRO
IPC: A61M5/34
Filed: 1997-10-27
Granted: 2004-06-03
Abstract: A syringe is provided with a Luer-Lok portion for connecting an extension tube or the like. The Luer-Lok portion (1) is arranged upright on a plane (4) of truncation of a conical-frustum-shaped free end portion of the syringe, and includes an inner cylindrical portion (3) and an outer cylindrical portion (2) surrounding the inner cylindrical portion (3) and having at least two projecting helical ribs formed in parallel with each other on an inner peripheral surface (2') thereof. The extension tube or the like can be connected to the Luer-Lok portion (1) by screwing at least two projecting helical ribs (a',b') of a cylindrical connector (8), said at least two projecting helical ribs (a',b') being formed in parallel with each other on an outer peripheral surface of the cylindrical connector (8), in corresponding grooves defined between the helical projecting ribs (a,b) of the outer cylindrical portion (2). A lower end portion of at least one of the projecting helical ribs (a,b) of the Luer-Lok portion (1) is formed at a position higher (h) than an upper surface (5) of a bottom wall between both of the cylindrical portions (2)(3).
Patent DE-69724639-T2 (DE)
Inventor: WARNER CLIFFORD ROY
IPC: B03C1/28
Filed: 1997-12-01
Granted: 2004-07-01
Abstract: A device and method for removing metalliferous particles from a powder so that the powder can be reused. A contaminated powder fluid stream flows down tube (6/7) into zones A, B and C adjacent the surface of a magnet (4). The flow flows past the surface of the magnet (4) and is directed towards the surface of the magnet (4) by baffles (10A, 10B). The magnet (4) separates metallic particles from powder particles and these metallic particles are removed from the face of the magnet (4) by scraper bars (21) conveyed by endless belts (22) supported by roller sets (23). The device can also include a fan (5) for promoting the movement of air in a counter direction to the delivered powder mixture.
Patent DE-69728061-T2 (DE)
Inventor: LAMBERT HANS
IPC: A61M16/22
Filed: 1997-11-18
Granted: 2005-03-03
Abstract: The invention relates to a regenerative absorber device (20) for the removal of CO2 from expiration gases during anesthesia. The device comprises a container (38) having an inlet (39) for said expiration gases, and an outlet (41) for output gases, the CO2 content of which having been substantially removed therefrom. The device is provided with an ion exchanger (42) having the capability to absorb CO2, disposed in said container (38) such that the gases flow through said ion exchanger from said inlet (39) to said outlet (41). A novel method of anesthesia comprises use of a CO2 absorber device according to the invention.
Patent DE-69801502-T2 (DE)
Inventor: OSTBO BERTIL
IPC: C02F11/02
Filed: 1998-06-18
Granted: 2002-05-08
Abstract: Arrangement for collecting and composting night-soil and other biodegradable material, comprising a space (23) in which a starting bed (29) has been spread out in order to accelerate the breakdown of material (30) which is dropped down onto the starting bed. The space (23) is lined with an inner layer of a flexible, liquid-impermeable material forming a sack-like container (8) which is open at the top. The starting bed (29) is arranged in the sack-like container, and the arrangement comprises members (40) for pressing the upper edge portion of the container against a ceiling (36) which is located under the floor (32) of at least one overhead toilet and is provided with at least one opening for attachment to a toilet bowl. The sack-like container (8) is designed to enclose the material (30) while the latter is being broken down, and the container comprises members for conveying liquid, which has been separated off from the material, via a screen arrangement (31). The sack-like container (8) is also designed to serve as an enclosure for transporting the completely or partially broken down material. The invention also relates to a method for collecting and composting night-soil.
Patent DE-69801802-T2 (DE)
Inventor: KHAN H
IPC: C12Q1/68
Filed: 1998-03-23
Granted: 2002-04-04
Abstract: Substituted propargylethoxyamido nucleosides are disclosed having the structure   <IMAGE>   wherein X is selected from the group consisting of amino alkanoic acid, alkylamino benzoic acid,  alpha -amino acid, and 4-amino-2-butynoic acid. R1 and R2 taken separately are selected from the group consisting of -H, lower alkyl, protecting group, and label; R3 is selected from the group consisting of -H and lower alkyl. B is a 7-deazapurine, purine, or pyrimidine nucleoside base. When B is purine or 7-deazapurine, the sugar moiety is attached at the N9-position of the purine or deazapurine, and when B is pyrimidine, the sugar moiety is attached at the N1-position of the pyrimidine. When B is a purine, the adjacent triple-bonded carbon is attached to the 8-position of the purine, when B is 7-deazapurine, the adjacent triple-bonded carbon is attached to the 7-position of the 7-deazapurine, and when B is pyrimidine, the adjacent triple-bonded carbon is attached to the 5-position of the pyrimidine. W1 is selected from the group consisting of -H and -OH. W2 is -OH or a moiety which renders the nucleoside incapable of forming a phosphodiester bond at the 3'-position. W3 is selected from the group consisting of -PO4, -P2O7, -P3O10, phosphate analog, and -OH. Additionaly, a primer extension method is provided employing the above X-substituted propargylethoxyamido nucleosides, and polynucleotides including the above X-substituted propargylethoxyamido nucleosides is provided.
Patent DE-69803397-T2 (DE)
Inventor: BOUSQUET ANDRE
IPC: C07C309/66
Filed: 1998-09-29
Granted: 2002-08-29
Abstract: Methyl (R)-2-(R<SUB>1</SUB>OSO<SUB>2</SUB>)-2-(2-chlorophenyl)acetates useful as intermediates in the preparation of methyl (S)-2(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno[3,2-c]-5-pyridyl)acetate.
Patent DE-69807879-T2 (DE)
Inventor: INNES A
IPC: B05C5/02
Filed: 1998-06-26
Granted: 2003-05-22
Abstract: A coating head, and coating apparatus and methods using the coating head, for applying a solvent free coating material to a strip article advancing longitudinally in a coating line. The head includes a die having a transverse slit through which the coating material is deposited on the strip surface and having a land portion with an extended land surface on the exit side of the slit, the die being supported for movement normal to the strip surface, and one or more air or hydraulic cylinders exerting a load on at least the land portion of the die to urge the land surface toward the strip, wherein the die is constituted of a main body and the land portion, and the land portion is so connected to the main die body as to be capable of flexing relative to the main die body in a direction normal to the strip surface but to resist flexing in the direction of strip advance in the coating line.